Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03288350
Title mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors McGill University Health Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.